Barriers and facilitators to liver fibrosis screening: Perspectives and practices of Canadian primary care physicians

Despite awareness of MASLD risk factors among Canadian PCPs, substantial gaps remain in screening due to limited knowledge, inconsistent tool use, and systemic barriers. These findings highlight the need for a coordinated national strategy to support PCPs in the early identification and referral of patients at risk for MASLD-related fibrosis.